Journal
NATURE MEDICINE
Volume 29, Issue 7, Pages 1581-1582Publisher
NATURE PORTFOLIO
DOI: 10.1038/d41591-023-00046-2
Keywords
-
Ask authors/readers for more resources
Nature Medicine reports on the latest translational and clinical research news, including FDA approval of Seres' orally administered pill SER-109 for the treatment of recurrent Clostridioides difficile infection.
Nature Medicine explores the latest translational and clinical research news, with FDA approval of Seres' orally administered pill SER-109 for the treatment of recurrent Clostridioides difficile infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
